echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > Premature birth may be due to premature activation of the fetal immune system

    Premature birth may be due to premature activation of the fetal immune system

    • Last Update: 2020-12-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    that pregnant women who develop inflammation as a result of the infection may activate the fetus' immune system prematurely, leading to premature birth, according to a new study published today.
    pregnancy usually lasts 40 weeks. Premature birth is a birth less than 37 weeks pregnant, which is the leading cause of neonatal death or long-term complications.
    researchers at the University of California, San Francisco and others tested the blood of 89 full-time women and 70 premature women, as well as the umbilical cord blood of the fetus. It was found that pre-premature children had higher levels of synth cells and effect T cells in cord blood.
    , the fetus' immune system usually does not respond "exclusively" to the mother during pregnancy, the researchers said. But in the case of inflammation in pregnant women, the fetal immune system may feel certain chemicals, and the tyroblades pass the information to the effect T cells, which start to activate the defense mechanism, mistaken the parent cells as "enemies" and launch attacks. Some of the chemicals released by the fetus' immune system in the process trigger the mother's uterus to contract, which can lead to premature birth.
    , an associate professor at the University of California, San Francisco, said it had been assumed that the fetus' immune system was immature and not associated with complications during pregnancy. In fact, the fetal immune system may have been activated at an earlier time, so it is necessary to analyze the risk of premature birth from this perspective. The team is looking for biomarkers in the mother's blood that can be used to determine this risk. (Source: Xinhua Zhouzhou)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.